HomeZVRA • NASDAQ
add
Zevra Therapeutics Inc
Previous close
$6.54
Day range
$6.42 - $6.95
Year range
$3.89 - $7.28
Market cap
275.81M USD
Avg Volume
354.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 3.42M | 7.84% |
Operating expense | 23.74M | 49.45% |
Net income | -16.62M | -25.76% |
Net profit margin | -485.31 | -16.62% |
Earnings per share | -0.40 | -17.65% |
EBITDA | -18.92M | -48.40% |
Effective tax rate | 0.42% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 52.72M | -44.67% |
Total assets | 151.28M | 41.92% |
Total liabilities | 102.46M | 191.17% |
Total equity | 48.82M | — |
Shares outstanding | 41.85M | — |
Price to book | 5.59 | — |
Return on assets | -31.65% | — |
Return on capital | -51.54% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -16.62M | -25.76% |
Cash from operations | -16.16M | -299.63% |
Cash from investing | 14.79M | 184.27% |
Cash from financing | 1.22M | 132.45% |
Net change in cash | -200.00K | 99.21% |
Free cash flow | -6.65M | -165.85% |
About
Founded
2006
Website
Employees
67